Neurocrine Biosciences, Inc.
MX ˙ BMV ˙ US64125C1099
SecurityMX:NBIX / Neurocrine Biosciences, Inc.
InstitutionJanney Montgomery Scott LLC
Latest Disclosed Ownership10,764 shares
Latest Disclosed Value $ 1,418
Janney Montgomery Scott LLC reports 2.46% decrease in ownership of NBIX / Neurocrine Biosciences, Inc.

On April 22, 2026 - Janney Montgomery Scott LLC filed a 13F-HR form disclosing ownership of 10,764 shares of Neurocrine Biosciences, Inc. (MX:NBIX) valued at $1,418 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 11,036 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of -2.46% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 10,764 -272 -2.46 1 0.00 0.0035
2026-02-11 2025-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 11,036 -1,779 -13.88 2 0.00 0.0036
2025-10-27 2025-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 12,815 -883 -6.45 2 0.00 0.0043
2025-07-17 2025-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 13,698 830 6.45 2 0.00 0.0045
2025-04-17 2025-03-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 12,868 -4,677 -26.66 1 -50.00 0.0040
2025-01-17 2024-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 17,545 1,150 7.01 2 100.00 0.0066
2024-10-29 2024-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 16,395 -413 -2.46 2 -50.00 0.0053
2024-07-25 2024-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 16,808 7,901 88.71 2 100.00 0.0071
2024-05-01 2024-03-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 8,907 270 3.13 1 0.00 0.0037
2024-02-08 2023-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 8,637 4,030 87.48 1 0.0037
2023-11-08 2023-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 4,607 348 8.17 1 0.0019
2023-07-26 2023-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 4,259 -44,204 -91.21 0 -100.00 0.0014
2023-04-28 2023-03-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 48,463 3,460 7.69 5 -20.00 0.0200
2023-02-01 2022-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 45,003 41,119 1,058.68 5 -98.79 0.0209
2022-10-25 2022-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 3,884 1,675 75.83 413 92.09 0.0018
2022-08-03 2022-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 2,209 -1,062 -32.47 215 -29.97 0.0010
2022-05-04 2022-03-31 13F MASTEC Common Stock 64125C109 3,271 -166 -4.83 307 4.78 0.0013
2022-01-27 2021-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 3,437 -12,334 -78.21 293 -80.62 0.0011
2021-10-29 2021-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 15,771 799 5.34 1,512 3.77 0.0065
2021-07-26 2021-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 14,972 -2,784 -15.68 1,457 -15.63 0.0064
2021-04-27 2021-03-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 17,756 12,373 229.85 1,727 234.69 0.0084
2021-01-25 2020-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 5,383 -7,247 -57.38 516 -57.53 0.0025
2020-11-06 2020-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 12,630 742 6.24 1,215 -16.21 0.0069
2020-07-23 2020-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 11,888 172 1.47 1,450 43.00 0.0092
2020-04-30 2020-03-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 11,716 1,198 11.39 1,014 -10.34 0.0080
2020-01-21 2019-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 10,518 -653 -5.85 1,131 12.31 0.0074
2019-10-29 2019-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 11,171 309 2.84 1,007 9.81 0.0073
2019-07-29 2019-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 10,862 1,545 16.58 917 11.69 0.0070
2019-04-30 2019-03-31 13F/A-1 NEUROCRINE BIOSCIENCES Common Stock 64125C109 9,317 9,317 821 0.0068
2017-02-13 2016-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 0 -8,924 -100.00 0 -100.00
2016-11-14 2016-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 8,924 -1,096 -10.94 452 -20.28 0.0080
2016-08-05 2016-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 10,020 1,096 12.28 567 60.62 0.0090
2016-05-10 2016-03-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 8,924 -1,096 -10.94 353 -37.74 0.0092
2016-02-19 2015-12-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 10,020 0 0.00 567 42.11 0.0146
2015-11-16 2015-09-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 10,020 596 6.32 399 -11.33 0.0113
2015-08-04 2015-06-30 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 9,424 2,023 27.33 450 53.06 0.0094
2015-05-12 2015-03-31 13F/A-1 NEUROCRINE BIOSCIENCES Common Stock 64125C109 7,401 7,401 294 0.0055
2015-04-30 2015-03-31 13F NEUROCRINE BIOSCIENCES Common Stock 64125C109 7,401 294
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.